Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Friday May 31, 2024
Friday May 31, 2024
touchEXPERT OPINIONS for touchONCOLOGY
A gynaecological oncologist considers the expanding role of molecular classification in endometrial cancer and provides an update on the use of immune checkpoint inhibitors to treat patients with advanced or recurrent disease, including key guideline recommendations, supporting data and considerations for clinical practice.
The expert
- Prof. David Cibula, General University Hospital and Charles University, Prague, Czech Republic
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck & Co, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/immunotherapy-in-endometrial-cancer/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.